Understanding Your Diagnosis: Dianzani ALPS and RALD

It is completely normal to feel overwhelmed after receiving a diagnosis as rare and complex as RAS-associated autoimmune leukoproliferative disease (RALD). For many years, this condition was often referred to as Dianzani ALPS or ALPS Type IV ^[1]. While those older terms may still be found in medical records, doctors now use the term RALD to more accurately reflect the genetic cause of the disease.

The first thing to understand is that RALD is an ALPS-like condition. This means it shares many features with Autoimmune Lymphoproliferative Syndrome (ALPS), but it is caused by a different biological “glitch.” While classic ALPS is caused by a failure in the body’s cell-suicide program (apoptosis), RALD is caused by overactive signals that tell certain white blood cells to keep growing ^[2][3].

Navigating an Exceptionally Rare Diagnosis

Finding information on RALD can be difficult because it is among the rarest conditions in the world. In a recent literature review, there were fewer than 50 documented cases ^[1][4]. Because so few people have this condition, your medical team may be learning alongside you.

It is natural to feel isolated or fearful when a disease is this rare. However, the medical community’s understanding of RALD is growing. Published cases describe it as having an indolent (slow-moving) course, though children require long-term monitoring by specialists in pediatric immunology and hematology ^[1][5].

Understanding Somatic Mutations and Inheritance

One of the most important things for parents to know is that RALD is caused by a somatic mutation ^[6]. In genetics, there are two main types of mutations:

• Germline mutations: These are present from the moment of conception and are inherited from a parent or passed down to children.
• Somatic mutations: These are “acquired” mutations that occur in a specific cell later in development ^[6].

In RALD, the mutation (usually in the NRAS or KRAS genes) happens only in certain blood-forming cells ^[1]. This means you did not pass this down to your child, and there was nothing you could have done to prevent it. Because the mutation is somatic, it is typically not found in the parents’ blood. Furthermore, siblings are generally not at increased risk of sharing the acquired mutation, and the reproductive risk is usually low (unless a geneticist confirms germline mosaicism) ^[7][8].

RALD vs. Classic ALPS: The Key Differences

While RALD and classic ALPS look very similar on the surface, they have distinct differences that your doctor will use to guide care.

Both conditions can cause an enlarged spleen (splenomegaly), swollen lymph nodes (lymphadenopathy), and low blood counts due to the immune system attacking its own cells (autoimmune cytopenias) ^[1][11].

Why the Name Changed

The shift from “Dianzani ALPS” to “RALD” represents a move toward precision medicine. “Dianzani” was a historical label used for patients who had all the symptoms of ALPS but had a normal FAS pathway ^[12]. Once researchers discovered that these specific cases were caused by mutations in the RAS gene family (NRAS and KRAS), the name was updated ^[13]. Using the name RALD helps doctors focus on the specific biological pathway involved, which is essential for choosing the right monitoring strategies.